Follow-The-Filings

Security · featured owners

LRMR Larimar Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 1.2%
  • $6M
  • 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 1.2% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel reduce 1.2%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 1.2% Reduce −1.0% 2,008,164 $6M history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 24 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
424B5 Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 3.02,5.03,9.01 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
8-K 3.02,5.03,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 rows shown

Filed Form Detail Links
4 Period Jul 6, 2026 Filing Doc
4 Period May 19, 2026 · 6 forms Filing Doc
4 Period Feb 27, 2026 · 4 forms Filing Doc
4 Period Jan 26, 2026 · 4 forms Filing Doc
4 Period Jul 31, 2025 Filing Doc

Updated 2 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$36.95M -$80.6M -$165.67M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $90.18M $195.3M $142.02M
Total non-current assets * $5.76M $4.92M $3.82M
Total assets $95.94M $200.22M $145.84M
Total current liabilities $9.51M $24.36M $64.8M
Total non-current liabilities * $4.71M $4.06M $2.96M
Total equity $81.72M $171.81M $78.08M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$33.46M -$70.76M -$113.2M
Cash from investing $33.35M -$85.39M $100.31M
Cash from financing $0.03M $161.88M $65.09M
Net change in cash -$0.076M $5.74M $52.19M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders